基于免疫检查点分子的表型分析对肾细胞癌患者进行免疫分类。
Immunological classification of renal cell carcinoma patients based on phenotypic analysis of immune check-point molecules.
机构信息
Department of Urology, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Department of Clinical Research in Tumour Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
出版信息
Cancer Immunol Immunother. 2018 Jan;67(1):113-125. doi: 10.1007/s00262-017-2060-5. Epub 2017 Oct 3.
OBJECTIVES
To clarify comprehensive immunological signature patterns of tumour tissue-infiltrating lymphocytes in patients with renal cell carcinoma and show its clinical significance.
MATERIALS AND METHODS
We investigated the surface marker expressions of tumour tissue-infiltrating lymphocytes quantitatively and classified them based on their functional populations. We extracted 109 sets of tumour tissue-infiltrating lymphocytes from 80 patients who underwent surgical resection of renal cell carcinoma, of which 44 tumour tissue-infiltrating lymphocytes were multiply extracted from 15 patients. Each tumour tissue-infiltrating lymphocyte was characterised on the basis of functional T-cell populations using ten surface marker expressions measured by flow cytometry.
RESULTS
All sets of the tumour tissue-infiltrating lymphocytes were classified into three groups, which correlated significantly with Fuhrman grade (OR 0.253, 95% CI 0.094-0.678, P = 0.006). Importantly, both overall metastasis-free survival (HR 0.449, 95% CI 0.243-0.832, P = 0.011) and recurrence-free survival (HR 0.475, 95% CI 0.238-0.948, P = 0.035) of the patients with the higher marker expressions were significantly inferior to those of the patients with the lower marker expressions by multivariate analysis. Six specific genes for this classification identified by microarray analysis verified our results using the TCGA KIRC data set. In addition, we discovered the presence of intra-tumoural diversity in the classification of 3 (20%) of the 15 patients.
CONCLUSIONS
This study showed that the presence of classable diversity in the immunological signature of tumour tissue-infiltrating lymphocytes correlated with prognosis and tumour aggressiveness that was observed even within individual tumours in some patients with renal cell carcinoma.
目的
阐明肾细胞癌患者肿瘤组织浸润淋巴细胞的全面免疫特征模式,并展示其临床意义。
材料与方法
我们定量研究了肿瘤组织浸润淋巴细胞的表面标志物表达,并根据其功能群体进行分类。我们从 80 名接受肾细胞癌手术切除的患者中提取了 109 组肿瘤组织浸润淋巴细胞,其中 15 名患者的肿瘤组织浸润淋巴细胞多次提取。基于流式细胞术测量的 10 种表面标志物表达,根据功能 T 细胞群体对每个肿瘤组织浸润淋巴细胞进行特征描述。
结果
所有肿瘤组织浸润淋巴细胞均分为三组,与 Fuhrman 分级显著相关(OR 0.253,95%CI 0.094-0.678,P=0.006)。重要的是,通过多变量分析,具有较高标志物表达的患者的总体无转移生存率(HR 0.449,95%CI 0.243-0.832,P=0.011)和无复发生存率(HR 0.475,95%CI 0.238-0.948,P=0.035)均明显低于具有较低标志物表达的患者。微阵列分析确定的用于此分类的 6 个特定基因通过 TCGA KIRC 数据集验证了我们的结果。此外,我们发现,在 15 名患者中的 3 名(20%)中存在肿瘤内分类的多样性。
结论
本研究表明,肿瘤组织浸润淋巴细胞免疫特征的可分类多样性与预后和肿瘤侵袭性相关,甚至在一些肾细胞癌患者的单个肿瘤中也观察到了这种相关性。